Bone infection surgery publication overviews
This quarter we highlight solutions for bone infection surgery as the Bonalive indication of the quarter. We will share publication overviews with you below.
Cost-Effectiveness Study of One-Stage Treatment of Chronic Osteomyelitis with Bioactive Glass S53P4
The study by Geurts et al. (2019) was set up to evaluate the costs of a one-stage treatment of chronic osteomyelitis using bioactive glass S53P4 versus a two-stage treatment using gentamicin-loaded PMMA beads. The study reveals that one-stage treatment with bioactive glass S53P4 is cost-effective and shows a better clinical outcome. Read the article here.